The safety of kava: a regulatory perspective

Br J Clin Pharmacol. 2007 Oct;64(4):418-20. doi: 10.1111/j.1365-2125.2007.02933.x. Epub 2007 Jul 4.

Authors

W N Richardson¹, L Henderson

Affiliation

¹ Medicines and Healthcare products Regulatory Agency, Vigilance and Risk Management of Medicines, Market Towers, London, UK. william.richardson@mhra.gsi.gov.uk

No abstract available

MeSH terms

Consumer Product Safety / legislation & jurisprudence*
Humans
Kava / adverse effects*
United Kingdom